Llwytho...
Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Intern Med |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
The Japanese Society of Internal Medicine
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5337470/ https://ncbi.nlm.nih.gov/pubmed/28090055 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|